Episode 507: ASCO 2026 - TALAPRO-3
From The Uromigos · · 41 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Neeraj Aggarwal joins the show to discuss the phase 3 TALAPRO-3 trial of talazoparib and enzlautamide in metastatic hormone-sensitive prostate cancer, focusing on trial design, efficacy, safety, and genetic subsets.